International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

Press releases published on July 1, 2026

All Kotori Kawashima Project Launches Globally to Preserve Human Stories in the AI Era
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
Kyivstar Subsidiary Uklon Launches Visa Acceptance Platform, Strengthening Digital Payments Infrastructure in Ukraine
FreedomPay’s Gateway to Giving™ Turns Small Checkout Donations into Big Community Impact, Starting with the Cincinnati Reds Community Fund
Bit Origin Announces Balance Sheet Strengthening Following Strategic AI Infrastructure Acquisition
ibex Honors the Winners of the 5th Annual CX Leadership Awards at CCW Las Vegas
JenaValve Recaps Key Highlights Including Late-Breaking Clinical Data from New York Valves 2026
Creative Medical Technology Holdings Issues Mid-Year Update
Cuentas Executives Double Down on the Company’s Future with Open-Market Stock Purchases
Türkiye’s leading digital asset platform Paribu expands its platform into DeFi, yield, and equities
Berto Acquisition Corp. II Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing on or about July 6, 2026
MathCo Expands Databricks Center of Excellence to Help Retail and CPG Enterprises Operationalize Agentic AI
Rethink Food and Just Salad Roll Out Rethink Food Bowl for July
Amoéba has received marketing authorization in France for its biofungicide AXPERA
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA
Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA
Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA
Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA
Abivax announces trading resumption of its ordinary shares on Euronext Paris

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

International Tech Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.